0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
INFLUENTIAL PUBLICATIONS   |    
Bibliography for Substance Abuse: Diagnosis and Treatment
FOCUS 2007;5:184-186.

Abstract

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.

Abstract Teaser
Figures in this Article

National Institute on Alcohol Abuse and Alcoholism: Helping Patients Who Drink Too Much: A Clinician's Guide updated 2005 edition, http://pubs.niaaa.nih.gov/publications/practitioner/CliniciansGuide2005/clinicians_guide.htm
 
Baldisseri MR: Impaired healthcare professional.  Crit Care Med. 2007; 35(2 suppl): S106— S116
[PubMed]
[CrossRef]
 
Humphreys K, Moos RH: Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes.  Alcohol Clin Exp Res 2007; 31: 64— 68
[PubMed]
[CrossRef]
 
Li TK, Volkow ND, Baler RD, Egli M: The biological bases of nicotine and alcohol co-addiction.  Biol Psychiatry. 2007; 61: 1— 3
[PubMed]
[CrossRef]
 
Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA: Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.  Ann Intern Med. 2007; 146: 116— 127
[PubMed]
 
Naqvi, NH, Rudrauf D, Damasio H, Bechara A: Damage to the insula disrupts addiction to cigarette smoking.  Science 2007; 315: 531— 534
[PubMed]
[CrossRef]
 
White JM, Lopatko OV: Opioid maintenance: a comparative review of pharmacological strategies.  Expert Opin Pharmacother 2007; 8: 1— 11
[PubMed]
[CrossRef]
 
American Psychiatric Assocation: Practice guideline for the treatment of patients with substance use disorders, second edition, in American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. Arlington, VA, American Psychiatric Association, 2006, pp. 291— 563. http://www.psych.org/psych_pract/treatg/pg/SUD2ePG_04—28-06.pdf
 
Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group: Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.  JAMA 2006; 295: 2003— 2017
[PubMed]
[CrossRef]
 
Baler RD, Volkow ND: Drug addiction: the neurobiology of disrupted self-control.  Trends Mol Med 2006; 12: 559— 566
[PubMed]
[CrossRef]
 
Epstein DH, Preston KL, Stewart J, Shaham Y: Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.  Psychopharmacology 2006; 189: 1— 16
[PubMed]
[CrossRef]
 
Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group: Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.  JAMA 2006; 296: 47— 55
[PubMed]
[CrossRef]
 
Gray KM, Upadhyaya HP, Deas D, Brady KT: Advances in diagnosis of adolescent substance abuse.  Adolesc Med Clin 2006; 17: 411— 425
[PubMed]
 
Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST: A meta-analysis of voucher-based reinforcement therapy for substance use disorders.  Addiction 2006; 101: 192— 203
[PubMed]
[CrossRef]
 
Mitchell D, Angelone DJ: Assessing the validity of the Stages of Change Readiness and Treatment Eagerness Scale with treatment-seeking military service members.  Mil Med. 2006; 171: 900— 904
[PubMed]
 
Oslin DW, Brereton WH, O'Brien CP: Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.  Addict Biol 2006; 11: 397— 403
[PubMed]
[CrossRef]
 
Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, Blaine J, MacDonald M, DiMaria J, Lucero L, Kellogg S: Contingency management for the treatment of methamphetamine use disorders.  Am J Psychiatry 2006; 163: 1993— 1999
[PubMed]
[CrossRef]
 
Room R: Taking account of cultural and societal influences on substance use diagnoses and criteria, in Diagnostic Issues in Substance Use Disorders.  Arlington, VA, American Psychiatric Publishing, 2007
 
American Academy of Child and Adolescent Psychiatry: Practice parameter for the assessment and treatment of children and adolescents with substance use disorders.  J Am Acad Child Adolesc Psychiatry 2005; 44: 609— 621
[PubMed]
[CrossRef]
 
Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R: Brief motivational intervention at a clinic visit reduces cocaine and heroin use.  Drug Alcohol Depend 2005; 77: 49— 59
[PubMed]
[CrossRef]
 
Brady KT, Sinha R: Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.  Am J Psychiatry. 2005; 162: 1483— 1493
[PubMed]
[CrossRef]
 
Carroll KM, Onken LS: Behavioral therapies for drug abuse.  Am J Psychiatry 2005; 162: 1452— 1460
[PubMed]
[CrossRef]
 
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP: A double-blind, placebo-controlled trial of modafinil for cocaine dependence.  Neuropsychopharmacology 2005; 30: 205— 211
[PubMed]
[CrossRef]
 
Fals-Stewart W, Klostermann K, Yates BT, O'Farrell TJ, Birchler GR: Brief relationship therapy for alcoholism: a randomized clinical trial examining clinical efficacy and cost-effectiveness.  Psychol Addict Behav 2005; 19: 363— 371
[PubMed]
[CrossRef]
 
Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group: Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.  JAMA 2005; 293: 1617— 1625
[PubMed]
[CrossRef]
 
Hettema J, Steele J, Miller WR: Motivational interviewing.  Annu Rev Clin Psychol 2005; 1: 91— 111
[PubMed]
[CrossRef]
 
Hyman SE: Addiction: a disease of learning and memory.  Am J Psychiatry 2005; 162: 1414— 1422
[PubMed]
[CrossRef]
 
Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice.  Am J Psychiatry 2005; 162: 1403— 1413
[PubMed]
[CrossRef]
 
Le Foll B, Goldberg SR: Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans.  Trends Pharmacol Sci 2005; 26: 287— 293
[PubMed]
[CrossRef]
 
McKay JR, Lynch KG, Shepard DS, Pettinati HM: The effectiveness of telephone-based continuing care for alcohol and cocaine dependence.  Arch Gen Psychiatry 2005; 62: 199— 207
[PubMed]
[CrossRef]
 
O'Brien CP: Anticraving medications for relapse prevention: a possible new class of psychoactive medications.  Am J Psychiatry 2005; 162: 1423— 1431
[PubMed]
[CrossRef]
 
O'Brien CP, Gardner EL: Critical assessment of how to study addiction and its treatment: human and non-human animal models.  Pharmacol Ther 2005; 108: 18— 58
[PubMed]
[CrossRef]
 
Sullivan LE, Fiellin DA, O'Connor PG: The prevalence and impact of alcohol problems in major depression: a systematic review.  Am J Med 2005; 118: 330— 341
[PubMed]
[CrossRef]
 
Torrens M, Fonseca F, Mateu G, Farre M: Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis.  Drug Alcohol Depend 2005; 78: 1— 22
[PubMed]
[CrossRef]
 
Trenton AJ, Currier GW: Behavioural manifestations of anabolic steroid use.  CNS Drugs 2005; 19: 571— 595
[PubMed]
[CrossRef]
 
Vocci FJ, Acri J, Elkashef A: Medication development for addictive disorders: the state of the science.  Am J Psychiatry. 2005; 162: 1432— 1440
[PubMed]
[CrossRef]
 
Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS: Does recovery from substance use disorder matter in patients with bipolar disorder?  J Clin Psychiatry 2005; 66: 730— 735
[PubMed]
[CrossRef]
 
Arseneault L, Cannon M, Witton J, Murray RM: Causal association between cannabis and psychosis: examination of the evidence.  Br J Psychiatry 2004; 184: 110— 117
[PubMed]
[CrossRef]
 
Bouza C, Angeles M, Munoz A, Amate JM: Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.  Addiction 2004; 99: 811— 828

ONLINE EXCLUSIVE: Full text of article Efficacy and Safety of Naltrexone and Acamprosate


[PubMed]
[CrossRef]
 
Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ: Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients.  Arch Gen Psychiatry 2004; 61: 264— 272
[PubMed]
[CrossRef]
 
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40.  Bethesda, Md, Substance Abuse and Mental Health Source Administration , 2004.
 
Diclemente CC, Schlundt D, Gemmell L: Readiness and stages of change in addiction treatment.  Am J Addict 2004; 13: 103— 119
[PubMed]
[CrossRef]
 
Galanter M, Dermatis H, Glickman L, Maslansky R, Sellers MB, Neumann E, Rahman-Dujarric C: Network therapy: decreased secondary opioid use during buprenorphine maintenance.  J Subst Abuse Treat 2004; 26: 313— 318
[PubMed]
[CrossRef]
 
Gendel MH: Forensic and medical legal issues in addiction psychiatry.  Psychiatr Clin North Am 2004; 27: 611— 626
[PubMed]
[CrossRef]
 
Kaye DL: Office recognition and management of adolescent substance abuse.  Curr Opin Pediatr. 2004; 16: 532— 541
[PubMed]
[CrossRef]
 
Kosten TR, Kosten TA: New medication strategies for comorbid substance use and bipolar affective disorders.  Biol Psychiatry 2004; 56: 771— 777
[PubMed]
[CrossRef]
 
Lessov CN, Swan GE, Ring HZ, Khroyan TV, Lerman C: Genetics and drug use as a complex phenotype.  Subst Use Misuse 2004; 39: 1515— 1569
[PubMed]
[CrossRef]
 
Nestler EJ: Historical review: molecular and cellular mechanisms of opiate and cocaine addiction.  Trends Pharmacol Sci 2004; 25: 210— 218
[PubMed]
[CrossRef]
 
Pettinati HM: Antidepressant treatment of co-occurring depression and alcohol dependence.  Biol Psychiatry 2004; 56: 785— 792
[PubMed]
[CrossRef]
 
Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ: A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction.  Drug Alcohol Depend 2004; 74: 1— 13
[PubMed]
[CrossRef]
 
Mannuzza S, Klein RG, Moulton JL III: Does stimulant treatment place children at risk for adult substance abuse? a controlled, prospective follow-up study.  J Child Adolesc Psychopharmacol 2003; 13: 273— 282
[PubMed]
[CrossRef]
 
Chappel JN, DuPont RL: Twelve-step and mutual-help programs for addictive disorders.  Psychiatr Clin North Am 1999; 22: 425— 446
[PubMed]
[CrossRef]
 
Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: a meta-analytic review.  J Consult Clin Psychol 1999, 67: 563— 570
[PubMed]
[CrossRef]
 
Mello NK, Negus SS: Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures.  Neuropsychopharmacology 1996; 14: 375— 424
[PubMed]
[CrossRef]
 
Peteet JR: A closer look at the role of a spiritual approach in addictions treatment.  J Subst Abuse Treat . 1993; 10: 263— 267
[PubMed]
[CrossRef]
 
References Container
+

References

National Institute on Alcohol Abuse and Alcoholism: Helping Patients Who Drink Too Much: A Clinician's Guide updated 2005 edition, http://pubs.niaaa.nih.gov/publications/practitioner/CliniciansGuide2005/clinicians_guide.htm
 
Baldisseri MR: Impaired healthcare professional.  Crit Care Med. 2007; 35(2 suppl): S106— S116
[PubMed]
[CrossRef]
 
Humphreys K, Moos RH: Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes.  Alcohol Clin Exp Res 2007; 31: 64— 68
[PubMed]
[CrossRef]
 
Li TK, Volkow ND, Baler RD, Egli M: The biological bases of nicotine and alcohol co-addiction.  Biol Psychiatry. 2007; 61: 1— 3
[PubMed]
[CrossRef]
 
Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA: Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.  Ann Intern Med. 2007; 146: 116— 127
[PubMed]
 
Naqvi, NH, Rudrauf D, Damasio H, Bechara A: Damage to the insula disrupts addiction to cigarette smoking.  Science 2007; 315: 531— 534
[PubMed]
[CrossRef]
 
White JM, Lopatko OV: Opioid maintenance: a comparative review of pharmacological strategies.  Expert Opin Pharmacother 2007; 8: 1— 11
[PubMed]
[CrossRef]
 
American Psychiatric Assocation: Practice guideline for the treatment of patients with substance use disorders, second edition, in American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. Arlington, VA, American Psychiatric Association, 2006, pp. 291— 563. http://www.psych.org/psych_pract/treatg/pg/SUD2ePG_04—28-06.pdf
 
Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group: Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.  JAMA 2006; 295: 2003— 2017
[PubMed]
[CrossRef]
 
Baler RD, Volkow ND: Drug addiction: the neurobiology of disrupted self-control.  Trends Mol Med 2006; 12: 559— 566
[PubMed]
[CrossRef]
 
Epstein DH, Preston KL, Stewart J, Shaham Y: Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.  Psychopharmacology 2006; 189: 1— 16
[PubMed]
[CrossRef]
 
Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group: Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.  JAMA 2006; 296: 47— 55
[PubMed]
[CrossRef]
 
Gray KM, Upadhyaya HP, Deas D, Brady KT: Advances in diagnosis of adolescent substance abuse.  Adolesc Med Clin 2006; 17: 411— 425
[PubMed]
 
Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST: A meta-analysis of voucher-based reinforcement therapy for substance use disorders.  Addiction 2006; 101: 192— 203
[PubMed]
[CrossRef]
 
Mitchell D, Angelone DJ: Assessing the validity of the Stages of Change Readiness and Treatment Eagerness Scale with treatment-seeking military service members.  Mil Med. 2006; 171: 900— 904
[PubMed]
 
Oslin DW, Brereton WH, O'Brien CP: Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.  Addict Biol 2006; 11: 397— 403
[PubMed]
[CrossRef]
 
Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, Blaine J, MacDonald M, DiMaria J, Lucero L, Kellogg S: Contingency management for the treatment of methamphetamine use disorders.  Am J Psychiatry 2006; 163: 1993— 1999
[PubMed]
[CrossRef]
 
Room R: Taking account of cultural and societal influences on substance use diagnoses and criteria, in Diagnostic Issues in Substance Use Disorders.  Arlington, VA, American Psychiatric Publishing, 2007
 
American Academy of Child and Adolescent Psychiatry: Practice parameter for the assessment and treatment of children and adolescents with substance use disorders.  J Am Acad Child Adolesc Psychiatry 2005; 44: 609— 621
[PubMed]
[CrossRef]
 
Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R: Brief motivational intervention at a clinic visit reduces cocaine and heroin use.  Drug Alcohol Depend 2005; 77: 49— 59
[PubMed]
[CrossRef]
 
Brady KT, Sinha R: Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.  Am J Psychiatry. 2005; 162: 1483— 1493
[PubMed]
[CrossRef]
 
Carroll KM, Onken LS: Behavioral therapies for drug abuse.  Am J Psychiatry 2005; 162: 1452— 1460
[PubMed]
[CrossRef]
 
Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP: A double-blind, placebo-controlled trial of modafinil for cocaine dependence.  Neuropsychopharmacology 2005; 30: 205— 211
[PubMed]
[CrossRef]
 
Fals-Stewart W, Klostermann K, Yates BT, O'Farrell TJ, Birchler GR: Brief relationship therapy for alcoholism: a randomized clinical trial examining clinical efficacy and cost-effectiveness.  Psychol Addict Behav 2005; 19: 363— 371
[PubMed]
[CrossRef]
 
Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, Loewy JW, Ehrich EW; Vivitrex Study Group: Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.  JAMA 2005; 293: 1617— 1625
[PubMed]
[CrossRef]
 
Hettema J, Steele J, Miller WR: Motivational interviewing.  Annu Rev Clin Psychol 2005; 1: 91— 111
[PubMed]
[CrossRef]
 
Hyman SE: Addiction: a disease of learning and memory.  Am J Psychiatry 2005; 162: 1414— 1422
[PubMed]
[CrossRef]
 
Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice.  Am J Psychiatry 2005; 162: 1403— 1413
[PubMed]
[CrossRef]
 
Le Foll B, Goldberg SR: Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans.  Trends Pharmacol Sci 2005; 26: 287— 293
[PubMed]
[CrossRef]
 
McKay JR, Lynch KG, Shepard DS, Pettinati HM: The effectiveness of telephone-based continuing care for alcohol and cocaine dependence.  Arch Gen Psychiatry 2005; 62: 199— 207
[PubMed]
[CrossRef]
 
O'Brien CP: Anticraving medications for relapse prevention: a possible new class of psychoactive medications.  Am J Psychiatry 2005; 162: 1423— 1431
[PubMed]
[CrossRef]
 
O'Brien CP, Gardner EL: Critical assessment of how to study addiction and its treatment: human and non-human animal models.  Pharmacol Ther 2005; 108: 18— 58
[PubMed]
[CrossRef]
 
Sullivan LE, Fiellin DA, O'Connor PG: The prevalence and impact of alcohol problems in major depression: a systematic review.  Am J Med 2005; 118: 330— 341
[PubMed]
[CrossRef]
 
Torrens M, Fonseca F, Mateu G, Farre M: Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis.  Drug Alcohol Depend 2005; 78: 1— 22
[PubMed]
[CrossRef]
 
Trenton AJ, Currier GW: Behavioural manifestations of anabolic steroid use.  CNS Drugs 2005; 19: 571— 595
[PubMed]
[CrossRef]
 
Vocci FJ, Acri J, Elkashef A: Medication development for addictive disorders: the state of the science.  Am J Psychiatry. 2005; 162: 1432— 1440
[PubMed]
[CrossRef]
 
Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS: Does recovery from substance use disorder matter in patients with bipolar disorder?  J Clin Psychiatry 2005; 66: 730— 735
[PubMed]
[CrossRef]
 
Arseneault L, Cannon M, Witton J, Murray RM: Causal association between cannabis and psychosis: examination of the evidence.  Br J Psychiatry 2004; 184: 110— 117
[PubMed]
[CrossRef]
 
Bouza C, Angeles M, Munoz A, Amate JM: Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.  Addiction 2004; 99: 811— 828

ONLINE EXCLUSIVE: Full text of article Efficacy and Safety of Naltrexone and Acamprosate


[PubMed]
[CrossRef]
 
Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ: Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients.  Arch Gen Psychiatry 2004; 61: 264— 272
[PubMed]
[CrossRef]
 
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40.  Bethesda, Md, Substance Abuse and Mental Health Source Administration , 2004.
 
Diclemente CC, Schlundt D, Gemmell L: Readiness and stages of change in addiction treatment.  Am J Addict 2004; 13: 103— 119
[PubMed]
[CrossRef]
 
Galanter M, Dermatis H, Glickman L, Maslansky R, Sellers MB, Neumann E, Rahman-Dujarric C: Network therapy: decreased secondary opioid use during buprenorphine maintenance.  J Subst Abuse Treat 2004; 26: 313— 318
[PubMed]
[CrossRef]
 
Gendel MH: Forensic and medical legal issues in addiction psychiatry.  Psychiatr Clin North Am 2004; 27: 611— 626
[PubMed]
[CrossRef]
 
Kaye DL: Office recognition and management of adolescent substance abuse.  Curr Opin Pediatr. 2004; 16: 532— 541
[PubMed]
[CrossRef]
 
Kosten TR, Kosten TA: New medication strategies for comorbid substance use and bipolar affective disorders.  Biol Psychiatry 2004; 56: 771— 777
[PubMed]
[CrossRef]
 
Lessov CN, Swan GE, Ring HZ, Khroyan TV, Lerman C: Genetics and drug use as a complex phenotype.  Subst Use Misuse 2004; 39: 1515— 1569
[PubMed]
[CrossRef]
 
Nestler EJ: Historical review: molecular and cellular mechanisms of opiate and cocaine addiction.  Trends Pharmacol Sci 2004; 25: 210— 218
[PubMed]
[CrossRef]
 
Pettinati HM: Antidepressant treatment of co-occurring depression and alcohol dependence.  Biol Psychiatry 2004; 56: 785— 792
[PubMed]
[CrossRef]
 
Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ: A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction.  Drug Alcohol Depend 2004; 74: 1— 13
[PubMed]
[CrossRef]
 
Mannuzza S, Klein RG, Moulton JL III: Does stimulant treatment place children at risk for adult substance abuse? a controlled, prospective follow-up study.  J Child Adolesc Psychopharmacol 2003; 13: 273— 282
[PubMed]
[CrossRef]
 
Chappel JN, DuPont RL: Twelve-step and mutual-help programs for addictive disorders.  Psychiatr Clin North Am 1999; 22: 425— 446
[PubMed]
[CrossRef]
 
Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: a meta-analytic review.  J Consult Clin Psychol 1999, 67: 563— 570
[PubMed]
[CrossRef]
 
Mello NK, Negus SS: Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures.  Neuropsychopharmacology 1996; 14: 375— 424
[PubMed]
[CrossRef]
 
Peteet JR: A closer look at the role of a spiritual approach in addictions treatment.  J Subst Abuse Treat . 1993; 10: 263— 267
[PubMed]
[CrossRef]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 9.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 39.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 39.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 5.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 17.  >
Topic Collections
Psychiatric News
PubMed Articles